ResearcherOkayama UniversityActive in the last 2 years
Hiroyuki Terasawa
Matched on ORCID iD 0000-0002-7623-2807; OpenAlex author ID A5063220362. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- Clinical Significance of a Cell-Of-Origin-Based Classification in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1111/cas.70533↗
- Cysts or necrotic components in pancreatic ductal adenocarcinoma is associated with the risk of EUS-FNA/B complications including needle tract seeding. Co-author DOI 10.1016/j.pan.2023.10.018↗
- Association between BRCA Gene Variants and the Response to Modified FOLFIRINOX in Patients with Unresectable Pancreatic Cancer. Co-author DOI 10.18926/amo/65974↗
- Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer. Co-author DOI 10.1080/15384047.2021.1980312↗
- Utility of liquid biopsy using urine in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/15384047.2019.1638685↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shigeru Horiguchi · 5 shared papers, 2019–2026 · strength 0.74
- Paper Clinical Significance of a Cell-Of-Origin-Based Classification in Pancreatic Ductal Adenocarcinoma. DOI 10.1111/cas.70533↗
- Paper Association between BRCA Gene Variants and the Response to Modified FOLFIRINOX in Patients with Unresectable Pancreatic… DOI 10.18926/amo/65974↗
- Paper Cysts or necrotic components in pancreatic ductal adenocarcinoma is associated with the risk of EUS-FNA/B complications… DOI 10.1016/j.pan.2023.10.018↗
- Daisuke Uchida · 4 shared papers, 2019–2026 · strength 0.55
- Paper Clinical Significance of a Cell-Of-Origin-Based Classification in Pancreatic Ductal Adenocarcinoma. DOI 10.1111/cas.70533↗
- Paper Cysts or necrotic components in pancreatic ductal adenocarcinoma is associated with the risk of EUS-FNA/B complications… DOI 10.1016/j.pan.2023.10.018↗
- Paper Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer. DOI 10.1080/15384047.2021.1980312↗
- Koichiro Tsutsumi · 3 shared papers, 2023–2026 · strength 0.55
- Paper Clinical Significance of a Cell-Of-Origin-Based Classification in Pancreatic Ductal Adenocarcinoma. DOI 10.1111/cas.70533↗
- Paper Association between BRCA Gene Variants and the Response to Modified FOLFIRINOX in Patients with Unresectable Pancreatic… DOI 10.18926/amo/65974↗
- Paper Cysts or necrotic components in pancreatic ductal adenocarcinoma is associated with the risk of EUS-FNA/B complications… DOI 10.1016/j.pan.2023.10.018↗
- Yuki Fujii · 3 shared papers, 2023–2026 · strength 0.55
- Paper Clinical Significance of a Cell-Of-Origin-Based Classification in Pancreatic Ductal Adenocarcinoma. DOI 10.1111/cas.70533↗
- Paper Association between BRCA Gene Variants and the Response to Modified FOLFIRINOX in Patients with Unresectable Pancreatic… DOI 10.18926/amo/65974↗
- Paper Cysts or necrotic components in pancreatic ductal adenocarcinoma is associated with the risk of EUS-FNA/B complications… DOI 10.1016/j.pan.2023.10.018↗
- Kazuyuki Matsumoto · 4 shared papers, 2019–2023 · strength 0.52
- Paper Association between BRCA Gene Variants and the Response to Modified FOLFIRINOX in Patients with Unresectable Pancreatic… DOI 10.18926/amo/65974↗
- Paper Cysts or necrotic components in pancreatic ductal adenocarcinoma is associated with the risk of EUS-FNA/B complications… DOI 10.1016/j.pan.2023.10.018↗
- Paper Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer. DOI 10.1080/15384047.2021.1980312↗
- Hironari Kato · 4 shared papers, 2019–2023 · strength 0.52
- Paper Association between BRCA Gene Variants and the Response to Modified FOLFIRINOX in Patients with Unresectable Pancreatic… DOI 10.18926/amo/65974↗
- Paper Cysts or necrotic components in pancreatic ductal adenocarcinoma is associated with the risk of EUS-FNA/B complications… DOI 10.1016/j.pan.2023.10.018↗
- Paper Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer. DOI 10.1080/15384047.2021.1980312↗
- Soichiro Ako · 3 shared papers, 2019–2026 · strength 0.41
- Paper Clinical Significance of a Cell-Of-Origin-Based Classification in Pancreatic Ductal Adenocarcinoma. DOI 10.1111/cas.70533↗
- Paper Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer. DOI 10.1080/15384047.2021.1980312↗
- Paper Utility of liquid biopsy using urine in patients with pancreatic ductal adenocarcinoma. DOI 10.1080/15384047.2019.1638685↗
- Hideaki Kinugasa · 3 shared papers, 2019–2026 · strength 0.41
- Paper Clinical Significance of a Cell-Of-Origin-Based Classification in Pancreatic Ductal Adenocarcinoma. DOI 10.1111/cas.70533↗
- Paper Plasma KRAS mutations predict the early recurrence after surgical resection of pancreatic cancer. DOI 10.1080/15384047.2021.1980312↗
- Paper Utility of liquid biopsy using urine in patients with pancreatic ductal adenocarcinoma. DOI 10.1080/15384047.2019.1638685↗
- Tatsuya Kikuchi · 2 shared papers, 2023–2026 · strength 0.36
- Motoyuki Otsuka · 2 shared papers, 2023–2026 · strength 0.36
- Kazuya Yasui · 1 shared paper, 2026 · strength 0.22
- Kosei Takagi · 1 shared paper, 2026 · strength 0.22
- Kazuhiro Nouso · 2 shared papers, 2019–2021 · strength 0.19
- Shinichiro Muro · 1 shared paper, 2021 · strength 0.10
- Yuzo Umeda · 1 shared paper, 2021 · strength 0.10
- Ryuichi Yoshida · 1 shared paper, 2021 · strength 0.10
- Hiroyuki Okada · 1 shared paper, 2021 · strength 0.10
- Hiroyuki Okada · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.